Tuberculosis Vaccine
Anti-mycobacterial Th1-cell responses does not enhance protection against tuberculosis
Published in Vaccine Weekly, May 24th, 2006
According to a study from France and the Czech Republic, "Bordetella pertussis adenylate cyclase (CyaA) toxoid is a powerful nonreplicative immunization vector targeting dendritic cells, which has already been used successfully in prophylactic and therapeutic vaccination in various preclinical animal models. Here, we investigated the potential of CyaA, harboring strong mycobacterial immunogens, i.e., the immunodominant regions of antigen 85A or the complete sequence of the 6-kDa early secreted antigenic target (ESAT-6)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-24)
More Articles from Vaccine Weekly
- Clonorchiasis Vaccine
DNA encoding cysteine proteinase protects against clonorchiasis - Lyme Disease Vaccine
Oral vaccine reduces Borrelia burgdorferi carriage and protects against Lyme disease - Plague Vaccine
Intranasal Protollin/F1-V vaccine protects against plague infection - Smallpox Vaccine
IMVAMUNE is promising candidate as third generation smallpox vaccine - Tuberculosis Vaccine
Lipid-encapsulated BCG induces long-term protection against tuberculosis - Adenoviral Vector
Replication properties of human adenovirus in different animal species described - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
